Oceania · General news · The Australian

Orthocell partner receives US FDA clearance for marine-derived bone graft

Published by The Australian · Australia 11 h ago

Orthocell’s strategic partner Marine Biomedical has received US Food and Drug Administration (FDA) 510(k) clearance for PearlBone, a next-generation bone substitute developed…

Read the full article on The Australian Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.theaustralian.com.au)

Also worth reading

Brisbane Times

Melbourne Cup LIVE: Point Of Law wins the Melbourne Cup ahead of Zahrann and Juja Kibo

WAtoday

Melbourne Cup LIVE: Point Of Law wins the Melbourne Cup ahead of Zahrann and Juja Kibo

The Age

Orthocell partner receives US FDA clearance for marine-derived bone graft

Share

Also worth reading

Melbourne Cup LIVE: Point Of Law wins the Melbourne Cup ahead of Zahrann and Juja Kibo

Melbourne Cup LIVE: Point Of Law wins the Melbourne Cup ahead of Zahrann and Juja Kibo

ClearVue plants Hong Kong flag in Asian solar expansion

Melbourne Cup 2026 finishing order from first to last

Economic outlook darkens in latest RBA forecasts

European Car of the Year 2027: All seven finalists are electric cars